SGRY vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

SGRY

55.2
AI Score
VS
SGRY Wins

PACS

54.1
AI Score

Investment Advisor Scores

SGRY

55score
Recommendation
HOLD

PACS

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SGRY PACS Winner
Revenue 417.37M 2.85B PACS
Net Income -17.50M 157.06M PACS
Net Margin -4.2% 5.5% PACS
Operating Income 41.20M 229.37M PACS
ROE -2.8% 14.1% PACS
ROA -0.4% 2.8% PACS
Total Assets 4.59B 5.66B PACS
Cash 112.82M 164.45M PACS
Current Ratio 1.72 0.91 SGRY

Relative Price Performance (Last 90 Days)

SGRY 1M: -4.6% · 3M: +9.3% PACS 1M: -1.3% · 3M: +17.2%

Current Technical Phase

SGRY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $14.52

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $44.25

Fundamentals Snapshot

Metric SGRY PACS
Market Cap
Forward P/E 22.9 16.3
Trailing P/E 25.5
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS -0.69 1.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SGRY is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.